Following Cathie Wood: Heavily increased SpaceX position by over 140,000 shares, reduced holdings in semiconductor giants like AMD

On Friday, all three major U.S. stock indices closed lower: the S&P 500 fell 1.01% to 7,457.69 points, the Nasdaq dropped sharply by 1.40% to 25,520.24 points, and the Dow Jones declined relatively less, down 0.77% to 52,146.42 points. Amid this market correction, technology stocks broadly came under pressure.

On the same day, Cathie Wood significantly increased positions in frontier sectors such as aerospace, autonomous driving, and AI infrastructure, while reducing holdings in certain traditional tech and precision medicine stocks to reallocate capital.

Buying focus: Betting on the space economy and the autonomous driving revolution

ARK’s largest purchase of the day$SpaceX (SPCX.US)$ 147,805 shares, demonstrating strong confidence in the commercial space sector. SpaceX, as a global leader in commercial spaceflight, continues to widen its technological moat in areas such as rocket reusability and its Starlink satellite network.$Pony AI (PONY.US)$increased holdings by 133,285 shares,$WeRide (WRD.US)$added 32,861 shares, reflecting ARK’s optimistic outlook on the commercialization of Level 4 autonomous driving.

In terms of AI infrastructure,$CoreWeave (CRWV.US)$Received a substantial increase of 115,827 shares. CoreWeave focuses on GPU cloud computing services and benefits from the explosive growth in AI training demand. The defense technology sector is also gaining favor,$Kratos Defense & Security Solutions (KTOS.US)$and$AeroVironment (AVAV.US)$increased holdings by 115,812 shares and 37,077 shares, respectively, possibly reflecting optimism about the broad prospects of drone technology in both military and civilian applications.

In the precision medicine space,$COMPASS Pathways (CMPS.US)$added 101,791 shares,$Prime Medicine (PRME.US)$increased its position by 81,580 shares, indicating ARK’s continued confidence in the long-term value of psychedelic therapy and gene-editing technologies. Notably,$Netflix (NFLX.US)$also received an increase of 38,068 shares, potentially due to its innovative capabilities in AI-generated content and global expansion.

Selling activity: Optimizing portfolio structure, reallocating capital toward hard tech

The largest selling move was a reduction in$Iridium Communications (IRDM.US)$ 144,634 shares, which may reflect ARK’s reassessment of changing competitive dynamics in the satellite communications industry. Partial reductions were also seen in the biotech sector,$10x Genomics (TXG.US)$sold 111,013 shares,$AtaiBeckley (ATAI.US)$The sale of 70,667 shares may reflect a cautious stance toward elevated valuations in certain niche segments.

In fintech,$Robinhood (HOOD.US)$the sale of 79,220 shares may be linked to considerations around evolving regulatory conditions and intensifying competition. Even traditional tech giants saw adjustments,$Advanced Micro Devices (AMD.US)$with 23,573 shares sold,$Baidu (BIDU.US)$7,651 shares sold,$Cloudflare (NET.US)$and 7,273 shares reduced, indicating ARK’s relatively cautious approach toward mature tech stocks.

In the industrial sector,$Deere (DE.US)$and$Caterpillar (CAT.US)$positions were reduced by 5,781 shares and 2,166 shares respectively, possibly reflecting ARK’s reassessment of the pace of legacy industrial automation upgrades. Overall, this round of adjustments embodies ARK’s balanced capital allocation philosophy—combining offense and defense—and maintains a continued focus on hard-tech names with disruptive innovation potential amid market volatility.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

263K Views